Liraglutide for management of adolescent obesity

Available interventions for adolescents with obesity are based on behavioural therapy and lifestyle modification. A new randomized, controlled trial provides evidence of efficacy of a pharmacological therapy, liraglutide, for weight control in adolescent obesity. The indications for more widespread use of this medication in clinical practice are under discussion.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.


  1. 1.

    NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet 390, 2627–2642 (2017).

    Article  Google Scholar 

  2. 2.

    Kelishadi, R. et al. Controlling childhood obesity: A systematic review on strategies and challenges. J. Res. Med. Sci. 19, 993–1008 (2014).

    PubMed  PubMed Central  Google Scholar 

  3. 3.

    Bahia, L. et al. Overview of meta-analysis on prevention and treatment of childhood obesity. J. Pediatr. 95, 385–400 (2019).

    Article  Google Scholar 

  4. 4.

    Srivastava, G. et al. Clinical considerations regarding the use of obesity pharmacotherapy in adolescents with obesity. Obesity (Silver Spring) 27, 190–204 (2019).

    Article  Google Scholar 

  5. 5.

    Anderson, K. L. A review of the prevention and medical management of childhood obesity. Child Adolesc. Psychiatr. Clin. N. Am. 27, 63–76 (2018).

    Article  Google Scholar 

  6. 6.

    Lentferink, Y. E. et al. Efficacy of metformin treatment with respect to weight reduction in children and adults with obesity: a systematic review. Drugs 78, 1887–1901 (2018).

    CAS  Article  Google Scholar 

  7. 7.

    Lin, C. H. et al. An evaluation of liraglutide including its efficacy and safety for the treatment of obesity. Expert Opin. Pharmacother. 21, 275–285 (2020).

    CAS  Article  Google Scholar 

  8. 8.

    Tamborlane, W. V. et al. Liraglutide in children and adolescents with type 2 diabetes. N. Engl. J. Med. 381, 637–646 (2019).

    CAS  Article  Google Scholar 

  9. 9.

    Kelly, A. S. et al. A randomized, controlled trial of liraglutide for adolescents with obesity. N. Engl. J. Med. (2020).

    Article  PubMed  PubMed Central  Google Scholar 

  10. 10.

    Martinez, S. M. et al. Mechanisms linking childhood weight status to metabolic risk in adolescence. Pediatr. Diabetes 21, 203–209 (2020).

    CAS  Article  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Roya Kelishadi.

Ethics declarations

Competing interests

The author declares no competing interests.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Kelishadi, R. Liraglutide for management of adolescent obesity. Nat Rev Endocrinol 16, 405–406 (2020).

Download citation


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing